✦ LIBER ✦

Paclitaxel added to the cisplatin/etoposide regimen in extensive-stage small cell lung cancer — the use of complete response rate as the primary endpoint in phase II trials

✍ Scribed by Dowlati, Afshin; Crosby, Lori; Remick, Scot C.; Makkar, Vinit; Levitan, Nathan

Book ID: 118569513
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 80 KB
Volume: 32
Category: Article
ISSN: 0169-5002
DOI: 10.1016/s0169-5002(00)00220-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II trial of oral etoposide plus ci

Phase II trial of oral etoposide plus cisplatin in extensive stage small cell carcinoma of the lung: an Eastern Cooperative Oncology Group study

✍ Schiller, Joan H.; Ettinger, David S.; Larson, Marilyn M.; Gradishar, William; M 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 516 KB

Alternating chemotherapy with etoposide

Alternating chemotherapy with etoposide plus cisplatin and topotecan plus paclitaxel in patients with untreated, extensive-stage small cell lung carcinoma : A Phase II trial of the North Central Cancer Treatment Group

✍ James R. Jett; Alan K. Hatfield; Shauna Hillman; Michael D. Bauman; James A. Mai 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB 👁 3 views

## Abstract ## BACKGROUND The objective of this study was to test the response rate and toxicity of alternating chemotherapy in previously untreated patients with extensive‐stage small cell lung carcinoma (SCLC). ## METHODS Patients with histologically proven, extensive‐stage SCLC, with a perfor

Phase II trial of postoperative adjuvant

Phase II trial of postoperative adjuvant cisplatin and etoposide in patients with completely resected stage I-IIIa small cell lung cancer: The Japan Clinical Oncology Lung Cancer Study Group Trial (JCOG9101)

✍ Ryosuke Tsuchiya; Kenji Suzuki; Yukito Ichinose; Yoh Watanabe; Tsutomu Yasumitsu 📂 Article 📅 2005 🏛 CTSNet 🌐 English ⚖ 202 KB

The sequential administration of cisplat

The sequential administration of cisplatin-etoposide followed by topotecan in patients with extensive stage small cell lung cancer (SCLC). A multicenter phase II study

✍ D. Mavroudis; S. Agelaki; Ph. Palamidas; Ch. Kouroussis; A. Harpidou; M. Toubis; 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 173 KB

Randomized study of cyclophosphamide, do

Randomized study of cyclophosphamide, doxorubicin, and vincristine versus etoposide and cisplatin versus alternation of these two regimens in extensive small-cell lung cancer: A phase III trial of the Southeastern Cancer Study Group

📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 166 KB

Sequential Versus Alternating Administra

Sequential Versus Alternating Administration of Cisplatin/Etoposide and Topotecan as First-Line Treatment in Extensive-Stage Small-Cell Lung Cancer: Preliminary Results of a Phase III Trial of the Hellenic Oncology Research Group

✍ Michail Ignatiadis; Dimitris Mavroudis; Marinos Veslemes; John Boukovinas; Kosta 📂 Article 📅 2005 🏛 CIG Media Group, LP. 🌐 English ⚖ 152 KB